Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Abingdon Health PLC ( (GB:ABDX) ) has provided an update.
Abingdon Health plc, a specialist in rapid diagnostic test development and med-tech regulatory services, has appointed Cavendish Capital Markets Limited as its sole corporate broker and nominated adviser with immediate effect. The move consolidates the company’s advisory and broking relationships under a single City firm, potentially streamlining its access to capital markets and investor engagement as it pursues growth in the international diagnostics and medical device sectors.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £6.50 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall stock score is primarily influenced by its mixed financial performance, with strong revenue growth overshadowed by profitability and cash flow challenges. The technical analysis indicates a neutral trend, lacking strong momentum. The valuation is unattractive due to a negative P/E ratio and no dividend yield. These factors collectively result in a moderate overall score.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health plc is a UK-headquartered med-tech contract service provider specialising in the development, manufacturing and regulatory support of rapid diagnostic tests and broader in vitro diagnostics for an international customer base. Through its CDMO operations, the group offers lateral flow product development, technology transfer and manufacturing services across areas such as infectious disease, clinical and companion diagnostics, animal health and environmental testing, while its subsidiaries provide regulatory consultancy, quality management, analytical testing and performance evaluation from facilities in York and Doncaster in the UK and Madison, Wisconsin in the US.
Average Trading Volume: 111,963
Technical Sentiment Signal: Sell
Current Market Cap: £15.69M
For detailed information about ABDX stock, go to TipRanks’ Stock Analysis page.